Establishing risk of human experimentation with drugs: lessons from TGN1412

This publication has 22 references indexed in Scilit:

• TGN1412: Time to Change the Paradigm for the Testing of New Pharmaceuticals
  Alternatives to Laboratory Animals, 2006
• TGN1412—a regulator's perspective
  Nature Biotechnology, 2006
• Co-stimulatory agonists as immunological adjuvants
  Vaccine, 2006
• London's disastrous drug trial has serious side effects for research
  Nature, 2006
• Regulation of Immune Responses by T Cells
  New England Journal of Medicine, 2006
• Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
  New England Journal of Medicine, 2005
• Protecting Research Subjects — The Crisis at Johns Hopkins
  New England Journal of Medicine, 2002
• A Death in the Laboratory: The Politics of the Gelsinger Aftermath
  Molecular Therapy, 2001
• Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field.
  British Journal of Clinical Pharmacology, 1989
• Clinically significant adverse effects in a Phase 1 testing program
  Clinical Pharmacology & Therapeutics, 1978